Entera Bio Ltd.
ENTX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001638097
No open-market purchases or sales by Entera Bio Ltd. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $19.0M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Entera Bio Ltd. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- +4 vs. Q4 2025
- Shares held
- 7.87M
- −1.47M (−15.7%) vs. Q4 2025
- Total value
- $8.68M
- −$9.45M (−52.1%) vs. Q4 2025
- New holders
- 8
- 5 more added
- Sold out
- 4
- 7 more reduced
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ENTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $19.0M |
| Q1 2026 | 26 | $8.68M |
| Q4 2025 | 22 | $18.1M |
| Q3 2025 | 22 | $17.7M |
| Q2 2025 | 19 | $19.4M |
| Q1 2025 | 18 | $17.4M |
| Q4 2024 | 14 | $15.9M |
| Q3 2024 | 17 | $10.1M |
| Q2 2024 | 15 | $9.75M |
| Q1 2024 | 15 | $7.11M |
| Q4 2023 | 10 | $2.44M |
| Q3 2023 | 12 | $1.87M |
| Q2 2023 | 12 | $2.17M |
| Q1 2023 | 9 | $3.28M |
| Q4 2022 | 12 | $415.9K |
| Q3 2022 | 9 | $4.85M |
| Q2 2022 | 10 | $6.54M |
| Q1 2022 | 12 | $14.2M |
| Q4 2021 | 12 | $15.9M |
| Q3 2021 | 14 | $26.7M |
| Q2 2021 | 14 | $30.6M |
| Q1 2021 | 8 | $7.57M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Entera Bio Ltd.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| SBI Securities Co., Ltd. | 2 | $2 | 0.00% | +2 | New |
| Caitong International Asset Management Co., Ltd | 20 | $22 | 0.00% | +20 | New |
| Group One Trading, L.P. | 51 | $57 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 400 | $444 | 0.00% | +400 | New |
| UBS Group AG | 3,212 | $3.56K | 0.00% | +3,195+18,794.1% | Added |
| Persistent Asset Partners Ltd | 5,881 | $6.53K | 0.00% | +5,881 | New |
| JPMorgan Chase & Co | 7,150 | $7.15K | 0.00% | +7,150 | New |
| The PNC Financial Services Group, Inc. | 10,000 | $11.1K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 12,000 | $13.3K | 0.00% | −3,000−20.0% | Reduced |
| Point72 Asset Management, L.P. | 12,382 | $13.7K | 0.00% | −1,181,271−99.0% | Reduced |
| HRT Financial LP | 15,492 | $17.0K | 0.00% | +15,492 | New |
| Gem Investment Advisors, LLC | 19,135 | $21.2K | 0.02% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 21,136 | $23.5K | 0.00% | 00.0% | Unchanged |
| Diadema Partners LP | 23,260 | $25.8K | 0.01% | +23,260 | New |
| Jane Street Group, LLC | 32,915 | $36.5K | 0.00% | −41,149−55.6% | Reduced |
| HighTower Advisors, LLC | 36,830 | $40.9K | 0.00% | −6,310−14.6% | Reduced |
| Signature Estate & Investment Advisors LLC | 47,328 | $52.5K | 0.00% | 00.0% | Unchanged |
| Schonfeld Strategic Advisors LLC | 55,223 | $61.3K | 0.00% | −541,362−90.7% | Reduced |
| XTX Topco Ltd | 131,622 | $146.1K | 0.00% | +131,622 | New |
| Northern Trust Corp | 146,854 | $163.0K | 0.00% | −1,814−1.2% | Reduced |
| Marshall Wace, LLP | 195,780 | $217.3K | 0.00% | −431,550−68.8% | Reduced |
| Seven Fleet Capital Management LP | 205,542 | $228.2K | 0.07% | +70,224+51.9% | Added |
| Citadel Advisors LLC | 245,577 | $272.6K | 0.00% | +205,347+510.4% | Added |
| Parkman Healthcare Partners LLC | 288,670 | $320.4K | 0.03% | +13,597+4.9% | Added |
| Renaissance Technologies LLC | 473,442 | $525.5K | 0.00% | +365,441+338.4% | Added |
| Knoll Capital Management, LLC | 5,881,879 | $6.47M | 3.59% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −64,910−100.0% | Sold out |
| Superstring Capital Management LP | 0 | $0 | 0.00% | −17,142−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −12,327−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −11,890−100.0% | Sold out |